Paper · 23736366
Glucose-dependent insulinotropic polypeptide has impaired effect on abdominal, subcutaneous adipose tissue metabolism in obese subjects.
Asmar M and 5 others. Int J Obes (Lond), 2014. Cited by 44 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Glucose-dependent insulinotropic polypeptide has impaired effect on abdominal, subcutaneous adipose tissue metabolism in obese subjects. Papers, record 23736366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23736366
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Glucose-dependent insulinotropic polypeptide has impaired effect on abdominal, subcutaneous adipose tissue metabolism in obese subjects.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gastric Inhibitory Polypeptide | Major topic |
| Hyperglycemia | Major topic |
| Hyperinsulinism | Major topic |
| Insulin Resistance | Major topic |
| Obesity | Major topic |
| Subcutaneous Fat, Abdominal | Major topic |
| Adult | |
| Blood Glucose | |
| Glucose Clamp Technique | |
| Glucose Intolerance | |
| Glucose Tolerance Test | |
| Humans | |
| Male | |
| Receptors, Gastrointestinal Hormone | |
| Regional Blood Flow | |
| Triglycerides |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8,976,802 | Subcutaneous abdominal adipose tissue blood flow: variation within and between subjects and relationship to obesity. | Clin Sci (Lond) | 1996 | https://conductscience.org/library/papers/8976802 | PubMed |
| 2 | 17,848,629 | GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet. | Am J Physiol Endocrinol Metab | 2007 | https://conductscience.org/library/papers/17848629 | PubMed |
| 3 | 12,145,159 | Impaired postprandial adipose tissue blood flow response is related to aspects of insulin sensitivity. | Diabetes | 2002 | https://conductscience.org/library/papers/12145159 | PubMed |
| 4 | 21,815,989 | Glucose-dependent insulinotropic polypeptide: from pathophysiology to therapeutic opportunities in obesity-associated disorders. | Obes Rev | 2011 | https://conductscience.org/library/papers/21815989 | PubMed |
| 5 | 20,731,685 | Real-time contrast-enhanced ultrasound determination of microvascular blood volume in abdominal subcutaneous adipose tissue in man. Evidence for adipose tissue capillary recruitment. | Clin Physiol Funct Imaging | 2010 | https://conductscience.org/library/papers/20731685 | PubMed |
| 6 | 14,662,716 | Nitric oxide and beta-adrenergic stimulation are major regulators of preprandial and postprandial subcutaneous adipose tissue blood flow in humans. | Circulation | 2004 | https://conductscience.org/library/papers/14662716 | PubMed |
| 7 | 19,996,386 | On the role of glucose-dependent insulintropic polypeptide in postprandial metabolism in humans. | Am J Physiol Endocrinol Metab | 2010 | https://conductscience.org/library/papers/19996386 | PubMed |
| 8 | 20,008,019 | Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men. | J Clin Endocrinol Metab | 2010 | https://conductscience.org/library/papers/20008019 | PubMed |
| 9 | 12,068,290 | Inhibition of gastric inhibitory polypeptide signaling prevents obesity. | Nat Med | 2002 | https://conductscience.org/library/papers/12068290 | PubMed |
| 10 | 10,938,238 | Activation of alpha(2)-adrenergic receptors impairs exercise-induced lipolysis in SCAT of obese subjects. | Am J Physiol Regul Integr Comp Physiol | 2000 | https://conductscience.org/library/papers/10938238 | PubMed |
1 to 10 of 27
See all 27 referencesCited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,907,720 | Glucose-dependent insulinotropic polypeptide (GIP) signaling in visceral and subcutaneous adipose tissue: implications for obesity and metabolic disease-a narrative review with a structured literature search. | Rev Endocr Metab Disord | 2026 | https://conductscience.org/library/papers/42907720 | PubMed |
| 42,697,203 | Emerging role of GLP-1 mono, dual, and triple agonists in the management of MASH-related fibrosis. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42697203 | PubMed |
| 42,393,405 | GIP contributes to postprandial regulation of splanchnic blood supply in humans with type 2 diabetes: a randomised, single-blinded, placebo-controlled, crossover study. | Diabetologia | 2026 | https://conductscience.org/library/papers/42393405 | PubMed |
| 41,226,777 | Tirzepatide as a Potential Disease-Modifying Therapy in Lipedema: A Narrative Review on Bridging Metabolism, Inflammation, and Fibrosis. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226777 | PubMed |
| 40,732,974 | The Complex Gene-Carbohydrate Interaction in Type 2 Diabetes: Between Current Knowledge and Future Perspectives. | Nutrients | 2025 | https://conductscience.org/library/papers/40732974 | PubMed |
| 40,469,445 | The evolution of the therapeutic concept 'GIP receptor antagonism'. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/40469445 | PubMed |
| 38,579,777 | The interplay of glucose-dependent insulinotropic polypeptide in adipose tissue. | J Endocrinol | 2024 | https://conductscience.org/library/papers/38579777 | PubMed |
| 37,592,302 | GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease. | Cardiovasc Diabetol | 2023 | https://conductscience.org/library/papers/37592302 | PubMed |
| 36,837,756 | Relation of Aortic Waveforms with Gut Hormones following Continuous and Interval Exercise among Older Adults with Prediabetes. | Metabolites | 2023 | https://conductscience.org/library/papers/36837756 | PubMed |
| 36,509,857 | Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1. | Nat Rev Endocrinol | 2023 | https://conductscience.org/library/papers/36509857 | PubMed |
1 to 10 of 26
See all 26 cited byGenes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GIP | 2,695 | PubTator's text mining | https://conductscience.org/library/genes/2695 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23736366
GET https://conductscience.org/api/papers/v1/23736366/references?page=2